Clinical trials for Singapore's Covid-19 vaccine could start in August

Arcturus Therapeutics research assistant Marion Hong conducting research on a vaccine for the coronavirus at a laboratory in San Diego last month. - Reuters

SINGAPORE (The Straits Times/ANN): Many companies and partnerships are in the race to develop a vaccine to stem the spread of Covid-19, with Singapore well in the hunt.

Duke-NUS Medical School here and United States-based Arcturus Therapeutics are now conducting pre-clinical studies on a vaccine candidate they have developed. If the vaccine is seen to be safe in animals and if studies suggest that it will be safe in humans, it will be tested next on healthy adults.